This study is a Swedish historical cohort study in patients prescribed Atacand or Cozaar for hypertension by selected primary care centres. Data will be extracted anonymously from electronic medical records. In addition, data regarding morbidity and mortality will be collected by merging the cohort with the following national registries: the Hospital Discharge Register (Slutenvårdsregistret), the Cause of Death Register and the Heart Intensive Care Admission (RIKS-HIA)
Study Type
OBSERVATIONAL
Enrollment
14,000
oral once daily dose
once daily oral dose
Research Site
Uppsala, Sweden
The primary efficacy objective is to investigate, on basis of 'first to event', the development of new cardiovascular diseases (CVD).
Time frame: 1999 - 2007
Cardiovascular disease states and procedures in the background and over the entire observation period will be identified by use of ICD-9 and ICD-10 coding for diseases of the cardiovascular system. Specifically are death, acute cardiovascular events, new
Time frame: 1999 - 2007
Health care consumption will be assessed as contacts with health care providers, in-hospital time periods for cardiovascular disease states with associated therapeutic procedures, and times spent within various levels of care (e.g. ICU and general ward).
Time frame: 1999 - 2007
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.